Antidepressant Drug Interactions and the Cytochrome P450 System
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (Supplement) , 10-19
- https://doi.org/10.2165/00003088-199500291-00004
Abstract
The selective serotonin reuptake inhibitors (SSRIs) and venlafaxine display the following rank order of in vitropotency against the cytochrome P450 (CYP) isoenzyme CYP2D6 as measured by their...Keywords
This publication has 30 references indexed in Scilit:
- Noninvasive tests of CYP3A enzymesPharmacogenetics, 1994
- A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamineEuropean Journal of Clinical Pharmacology, 1994
- CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humansPharmacogenetics, 1993
- High-Performance Liquid Chromatography Determination of Dextromethorphan and Dextrorphan for Oxidation Phenotyping by Fluorescence and Ultraviolet DetectionTherapeutic Drug Monitoring, 1993
- Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6European Journal of Clinical Pharmacology, 1993
- Effect of Fluvoxamine on the Pharmacokinetics of Imipramine and Desipramine in Healthy SubjectsTherapeutic Drug Monitoring, 1993
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992
- Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).British Journal of Clinical Pharmacology, 1991
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991